Saira Sheikh/ med.unc.edu
May 17, 2026, 10:50
CAR T-Cell Therapy and Life-Changing Progress in Autoimmune Disease – UNC Health
UNC Health shared a post on LinkedIn:
“Clinical trials are essential for developing new treatments for serious conditions.
At the UNC School of Medicine, a groundbreaking CAR T-cell therapy clinical trial is giving patients with severe autoimmune diseases like lupus a chance at a life-changing reset.
‘We’re giving patients who have suffered for so long another chance, a reset at life,’ said UNC Health rheumatologist Saira Sheikh, MD.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
May 17, 2026, 16:34Abdul Mannan: A Normal Factor Level Can Still Miss the Story
-
May 17, 2026, 16:12Double Your Impact Help Close the Hemophilia Diagnosis Gap and Expand Access to Life Saving Care – WFH
-
May 17, 2026, 16:01Ney Carter Borges: Non-HDL Cholesterol vs ApoB Both Matter for ASCVD Risk
-
May 17, 2026, 15:59Seema Dawood: The Vital Link Between Hematology and Blood Banking
-
May 17, 2026, 15:57Samwel Mikaye: Clinical Features and Presentation of Iron Deficiency Anaemia
-
May 17, 2026, 15:56Krishna Kumar Dhakchinamoorthi: How AI-Powered Technologies Analyze Patient History to Detect and Predict DVT
-
May 17, 2026, 15:49Maia Meier: Are Women With Bleeding Disorders Being Underdiagnosed?
-
May 17, 2026, 15:46Alan Nurden: How the Interaction Between VWF and the aIIbβ3 Integrin in Platelets Consolidates Thrombi
-
May 17, 2026, 15:40Emma Groarke: A Practical Approach to Somatic Mutation and Cytogenetic Monitoring in Severe Aplastic Anemia